Ligand Pharmaceuticals Incorporated LGND Balance Sheet

Income Statement

Quarter End	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	1.05B	762.67M	811.08M	758.11M	769.23M	787.22M	913.87M	866.41M
Total Current Assets	220.43M	263.6M	328.2M	276.71M	253.99M	237.43M	368.91M	312.26M
Cash and Equivalents	4.12M	45.01M	88.73M	28.45M	19.28M	22.95M	50.09M	18.14M
Total Non-Current Assets	815.73M	507.45M	478.94M	477.63M	511.67M	562M	541.74M	551.06M
Total Liabilities	234.31M	165.18M	164.76M	93.21M	101.33M	86.3M	107.35M	91.21M
Total Current Liabilities	135.24M	98.81M	98.93M	29.39M	15.73M	16.78M	17.82M	18.57M
Total Non-Current Liabilities	99.07M	66.38M	65.83M	63.83M	85.6M	69.54M	89.53M	72.64M
Common Equity	17k	17k	17k	17k	18k	18k	18k	19k
Retained Earnings	468.35M	450.86M	492.81M	495.1M	484.83M	503.02M	589.16M	537.24M

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	601.59M	671.02M	1.26B	1.49B	1.36B	1.3B	762.67M	787.22M
Total Current Assets	163.05M	237.02M	870.54M	1.12B	500.56M	464.75M	263.6M	237.43M
Cash and Equivalents	18.75M	20.62M	117.16M	71.54M	47.62M	19.52M	45.01M	22.95M
Total Non-Current Assets	341.29M	399.79M	560.91M	767.23M	709.53M	821.16M	597.49M	700.91M
Total Liabilities	260.3M	271.23M	699.89M	727.68M	652.76M	476.43M	165.18M	86.3M
Total Current Liabilities	227.13M	238.87M	82.25M	17M	100.11M	41.67M	98.81M	16.78M
Total Non-Current Liabilities	33.17M	32.37M	1.23B	1.35B	995.05M	755.54M	66.38M	69.54M
Total Equity	341.29M	399.79M	560.91M	767.23M	709.53M	821.16M	597.49M	700.91M
Common Equity	21k	21k	21k	17k	16k	17k	17k	18k
Retained Earnings	-431.13M	-400.92M	-229.2M	400.11M	391.95M	449.09M	450.86M	503.02M